Fusion Antibodies Ltd are pleased to announce the in-licensing of the anti-AM2R monoclonal antibody from Medella Therapeutics, to use our CDRx™ humanization technology to develop it as a novel 1st in class therapy for serious cancers with…
Fusion Antibodies, a UK-based contract research organisation and MAB Discovery, a unique antibody discovery company, have announced their intention to enter into a research and licence agreement in the field of monoclonal antibodies.
Fusion Antibodies is set to double its workforce as part of an investment supported by Invest NI.
Its planned expansion, which also includes doubling revenues with the next three years, will create 15 jobs.
Invest NI has provided…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-03-15 09:35:272022-04-05 10:50:09Fusion Antibodies to double workforce with help from Invest NI
Fusion Antibodies will be attending the following events in 2016:
BioShowcase USA San Francisco January 10th
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and…
Fusion Antibodies are pleased to announce that we have been awarded a Crescent Capital Green Bar Award.
The award recognises the company’s achievement of five profitable quarters of growth in succession. The award was presented to…
Fusion Antibodies have some fantastic offers for you throughout February!
For all new customers, we are offering 25% off the in silico design stage of our best in market Ab Humanization services*.For all existing…
Fusion Antibodies are currently recruiting for a scientific position. Apply today at email@example.com
Fusion Antibodies are currently recruiting for a scientific position. Please see more details below or email firstname.lastname@example.org
Monoclonal antibodies, or mAbs, have become a crucial tool and are used for both diagnostic and medical applications. This article will explain the importance of mAbs and antibody humanization techniques involved.
If you are interested…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-01-15 10:51:152022-04-05 10:50:32Why is Antibody Humanization still important in the 21st century?
We would like to take this opportunity to wish you all a Merry Christmas and a Happy New Year!
Dear Fusion Antibodies Clients,
It has been a fantastic year for Fusion Antibodies with our humanization service in particular welcoming…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2015-12-15 10:57:242022-04-05 10:50:37Merry Christmas and Happy New Year!
Fusion Antibodies are happy to announce we will be attending BIO-Europe which is to be held from the 2nd to the 4th of November 2015.
BIO-Europe is the largest partnering conference in Europe and attracts thousands of companies and attendees…
Fusion Antibodies are pleased to announce that we will be attending the 2015 Human Antibodies and Hybridomas Conference, to be held 28-30th of October at the University of Lausanne, Switzerland.
Conference activities will include keynote…
Fusion Antibodies Ltd, an antibody drug and cell line development CRO focused on the treatment of serious disease, has signed an exclusive licensing agreement with Clarity Pharmaceuticals Ltd. (Sydney, Australia) to further develop Fusion’s…
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: